CSTL
Price
$34.35
Change
+$1.05 (+3.15%)
Updated
Oct 27, 04:06 PM (EDT)
Capitalization
1.02B
9 days until earnings call
Intraday BUY SELL Signals
STAA
Price
$23.21
Change
-$0.02 (-0.09%)
Updated
Oct 27, 11:09 AM (EDT)
Capitalization
1.16B
8 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CSTL vs STAA

CSTL vs STAA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CSTL vs. STAA commentary
Oct 27, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSTL is a Buy and STAA is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CSTL with price predictions
Oct 26, 2026

Aroon Indicator for CSTL shows an upward move is likely

CSTL's Aroon Indicator triggered a bullish signal on October 15, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 227 similar instances where the Aroon Indicator showed a similar pattern. In 205 of the 227 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 39 of 54 cases where CSTL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 72%.

The Momentum Indicator moved above the 0 level on October 26, 2026. You may want to consider a long position or call options on CSTL as a result. In 80 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 89%.

Following a +6.86% 3-day Advance, the price is estimated to grow further. Considering data from situations where CSTL advanced for three days, in 228 of 293 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.

CSTL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for CSTL turned negative on September 22, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 36 similar instances when the indicator turned negative. In 28 of the 36 cases the stock turned lower in the days that followed. This puts the odds of success at 78%.

CSTL moved below its 50-day moving average on October 22, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CSTL crossed bearishly below the 50-day moving average on October 19, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 83%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CSTL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 22 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.164) is normal, around the industry mean (65.624). P/E Ratio (-52.031) is within average values for comparable stocks, (2.414). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (2.947) is also within normal values, averaging (9.775).

The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. CSTL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 48 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 84 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CSTL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.

A.I.Advisor
a Summary for STAA with price predictions
Oct 26, 2026

STAA's RSI Indicator ascending out of oversold territory

The RSI Indicator for STAA moved out of oversold territory on September 25, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 41 similar instances when the indicator left oversold territory. In 34 of the 41 cases the stock moved higher. This puts the odds of a move higher at 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 22, 2026. You may want to consider a long position or call options on STAA as a result. In 78 of 104 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 75%.

The Moving Average Convergence Divergence (MACD) for STAA just turned positive on September 29, 2026. Looking at past instances where STAA's MACD turned positive, the stock continued to rise in 35 of 47 cases over the following month. The odds of a continued upward trend are 74%.

STAA moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +3.29% 3-day Advance, the price is estimated to grow further. Considering data from situations where STAA advanced for three days, in 192 of 274 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The 50-day moving average for STAA moved below the 200-day moving average on September 22, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

STAA broke above its upper Bollinger Band on October 26, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for STAA entered a downward trend on October 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 44 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 51 (best 1 - 100 worst), indicating steady price growth. STAA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 89 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.188) is normal, around the industry mean (4.950). STAA's P/E Ratio (290.375) is considerably higher than the industry average of (37.710). Projected Growth (PEG Ratio) (2.060) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (3.331) is also within normal values, averaging (56.876).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STAA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

FUNDAMENTALS RATINGS
CSTL vs STAA: Fundamental Ratings
CSTL
STAA
OUTLOOK RATING
1..100
3745
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
98
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9289
PRICE GROWTH RATING
1..100
3951
P/E GROWTH RATING
1..100
8444
SEASONALITY SCORE
1..100
4850

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CSTL's Valuation (22) in the null industry is significantly better than the same rating for STAA (98) in the Medical Specialties industry. This means that CSTL’s stock grew significantly faster than STAA’s over the last 12 months.

CSTL's Profit vs Risk Rating (100) in the null industry is in the same range as STAA (100) in the Medical Specialties industry. This means that CSTL’s stock grew similarly to STAA’s over the last 12 months.

STAA's SMR Rating (89) in the Medical Specialties industry is in the same range as CSTL (92) in the null industry. This means that STAA’s stock grew similarly to CSTL’s over the last 12 months.

CSTL's Price Growth Rating (39) in the null industry is in the same range as STAA (51) in the Medical Specialties industry. This means that CSTL’s stock grew similarly to STAA’s over the last 12 months.

STAA's P/E Growth Rating (44) in the Medical Specialties industry is somewhat better than the same rating for CSTL (84) in the null industry. This means that STAA’s stock grew somewhat faster than CSTL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CSTLSTAA
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
76%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
Bearish Trend 6 days ago
78%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
68%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
68%
Advances
ODDS (%)
Bullish Trend 7 days ago
78%
Bullish Trend 2 days ago
70%
Declines
ODDS (%)
Bearish Trend 5 days ago
79%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
76%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
COMPARISON
Comparison
Oct 27, 2026
Stock price -- (CSTL: $33.30 vs. STAA: $23.23)
Brand notoriety: CSTL and STAA are both not notable
CSTL represents the Medical Specialties, while STAA is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CSTL: 69% vs. STAA: 85%
Market capitalization -- CSTL: $1.02B vs. STAA: $1.16B
CSTL [@Medical Specialties] is valued at $1.02B. STAA’s [@Pharmaceuticals: Other] market capitalization is $1.16B. The market cap for tickers in the [@Medical Specialties] industry ranges from $27 to $4.39T. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $159.55B. The average market capitalization across the [@Medical Specialties] industry is $21.08B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $9.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CSTL’s FA Score shows that 1 FA rating(s) are green while STAA’s FA Score has 0 green FA rating(s).

  • CSTL’s FA Score: 1 green, 4 red.
  • STAA’s FA Score: 0 green, 5 red.
According to our system of comparison, CSTL is a better buy in the long-term than STAA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CSTL’s TA Score shows that 5 TA indicator(s) are bullish while STAA’s TA Score has 5 bullish TA indicator(s).

  • CSTL’s TA Score: 5 bullish, 4 bearish.
  • STAA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both CSTL and STAA are a good buy in the short-term.

Price Growth

CSTL (@Medical Specialties) experienced а +3.53% price change this week, while STAA (@Pharmaceuticals: Other) price change was +6.17% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.19%. For the same industry, the average monthly price growth was -5.98%, and the average quarterly price growth was +48.59%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.27%. For the same industry, the average monthly price growth was -3.10%, and the average quarterly price growth was +10.31%.

Reported Earning Dates

CSTL is expected to report earnings on Nov 05, 2026.

STAA is expected to report earnings on Nov 04, 2026.

Industries' Descriptions

@Medical Specialties (+2.19% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Pharmaceuticals: Other (+0.27% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

View a ticker or compare two or three
CSTL
Daily Signal:
Gain/Loss:
STAA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

STAA and

Correlation & Price change

A.I.dvisor indicates that over the last year, STAA has been loosely correlated with OFIX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if STAA jumps, then OFIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STAA
1D Price
Change %
STAA100%
+2.74%
OFIX - STAA
38%
Loosely correlated
-0.31%
CSTL - STAA
38%
Loosely correlated
+0.67%
IQV - STAA
37%
Loosely correlated
-2.06%
MTD - STAA
37%
Loosely correlated
-0.04%
FLGT - STAA
36%
Loosely correlated
+0.60%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DNTH79.332.55
+3.32%
Dianthus Therapeutics
ZS260.455.30
+2.08%
Zscaler
DHX4.660.02
+0.43%
DHI Group
RHLD119.630.11
+0.09%
Resolute Holdings Management
VIDA1.01-0.05
-4.48%
Vida Global Inc